These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22858556)

  • 21. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital.
    Boom JA; Tate JE; Sahni LC; Rench MA; Quaye O; Mijatovic-Rustempasic S; Patel MM; Baker CJ; Parashar UD
    Pediatr Infect Dis J; 2010 Dec; 29(12):1133-5. PubMed ID: 20634776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing rotavirus gastroenteritis: do you have the facts?
    Davidson G; Elliott EJ; Kirkwood C; Pearce R
    J Paediatr Child Health; 2007; 43(7-8):564-7. PubMed ID: 17635688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.
    Paulke-Korinek M; Kundi M; Rendi-Wagner P; de Martin A; Eder G; Schmidle-Loss B; Vecsei A; Kollaritsch H
    Vaccine; 2011 Mar; 29(15):2791-6. PubMed ID: 21320539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.
    Clarke MF; Davidson GP; Gold MS; Marshall HS
    Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute rotavirus gastroenteritis in children younger than 5 years of age after initiation of rotavirus immunization schedule.
    García-Puebla A; García-Fragoso L
    Bol Asoc Med P R; 2012; 104(1):4-7. PubMed ID: 22788071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a publicly funded monovalent rotavirus vaccination program in the Province of Quebec (Canada).
    Comeau JL; Gagneur A; Quach C
    Vaccine; 2016 Feb; 34(7):893-8. PubMed ID: 26795368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study.
    Gagneur A; Nowak E; Lemaitre T; Segura JF; Delaperrière N; Abalea L; Poulhazan E; Jossens A; Auzanneau L; Tran A; Payan C; Jay N; de Parscau L; Oger E;
    Vaccine; 2011 May; 29(21):3753-9. PubMed ID: 21443962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama.
    Bayard V; DeAntonio R; Contreras R; Tinajero O; Castrejon MM; Ortega-Barría E; Colindres RE
    Int J Infect Dis; 2012 Feb; 16(2):e94-8. PubMed ID: 22154592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
    Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
    Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
    Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
    J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh.
    Feller AJ; Zaman K; Lewis KD; Hossain I; Yunus M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A101-5. PubMed ID: 22520118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of rotavirus vaccination on epidemiological dynamics in England and Wales.
    Atkins KE; Shim E; Pitzer VE; Galvani AP
    Vaccine; 2012 Jan; 30(3):552-64. PubMed ID: 22133508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.
    Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD
    Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of rotavirus vaccination in Spain.
    Martinón-Torres F; Bouzón Alejandro M; Redondo Collazo L; Sánchez Lastres JM; Pértega Díaz S; Seoane Pillado MT; Martinón Sánchez JM;
    Hum Vaccin; 2011 Jul; 7(7):757-61. PubMed ID: 21521947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.
    Bawa Z; Elliot AJ; Morbey RA; Ladhani S; Cunliffe NA; O'Brien SJ; Regan M; Smith GE
    Clin Infect Dis; 2015 Jul; 61(1):77-85. PubMed ID: 25828997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.